Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Escalation Study Of The Safety, Tolerability, And Pharmacokinetics Of Cabazitaxel In Combination With Cisplatin Administered Every 3 Weeks In Subjects With Advanced Solid Malignancies

NCT00925743 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00925743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00925743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Escalation Study Of The Safety, Tolerability, And Pharmacokinetics Of Cabazitaxel In Combination With Cisplatin Administered Every 3 Weeks In Subjects With Advanced Solid Malignancies
Lead sponsor
Sanofi
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2009
Completion date
March 31, 2013
Enrollment
76 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

solid cancer